FolioMetrix’s iShares Biotechnology ETF IBB Stock Holding History

FolioMetrix’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$4.21M	Buy	40,473 +8,310	+26%	+$995K	1.76%	23
2015 Q1	$3.68M	Buy	32,163 +7,080	+28%	+$781K	1.86%	16
2014 Q4	$2.44M	Buy	+25,083	New	+$2.44M	1.72%	18

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

FolioMetrix's IBB Position: Q2 2015 in Review

FolioMetrix increased its iShares Biotechnology ETF (IBB) stake by 26% in Q2 2015, buying an estimated $995K and bringing the position to 40,473 shares worth $4.21M. The position accounts for 1.76% of the portfolio, ranked #23.

FolioMetrix first reported a position in IBB in Q4 2014 and has held it in 3 quarters since. 420 funds tracked by Wall St. Rank hold IBB as of Q2 2015.

FolioMetrix held 40,473 shares of iShares Biotechnology ETF worth $4.21M as of Q2 2015.
FolioMetrix bought 8,310 iShares Biotechnology ETF shares in Q2 2015, an estimated $995K.
iShares Biotechnology ETF made up 1.76% of FolioMetrix's portfolio in Q2 2015, its #23 holding.
FolioMetrix first reported a position in iShares Biotechnology ETF in Q4 2014 and has held it in 3 quarters since.
420 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.